The Time for Cancer Vaccines Is Now

JAMA Oncology 2026

View at publisher
Authors: Kiranjit K. Dhillon, Lennard Y. W. Lee
DOI: 10.1001/jamaoncol.2025.6203
Cited by: 1
References: 7

Abstract

This Viewpoint discusses advances in cancer vaccines, including the use of COVID-19 pandemic–related infrastructure, clinical trial results, and harnessing artificial intelligence.

Fields of Study & Subjects

Immunotherapy and Immune Responses vaccines and immunoinformatics approaches Immune responses and vaccinations

Publication details

Journal / source
JAMA Oncology
Publisher
American Medical Association (AMA)
Volume
12
Issue
4
Pages
345–345
Publication date
12 February 2026
Language
EN